Welcome to CKB CORE's new home! Please be sure to update any bookmarks you may have.
×

Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name Pralsetinib
Trade Name Gavreto
Synonyms BLU667|BLU-667
Drug Descriptions

Gavreto (pralsetinib) is a small molecule inhibitor that selectively targets activated Ret, which may result in antitumor activity including inhibition of tumor growth and tumor regression (PMID: 29657135). Gavreto (pralsetinib) is FDA approved for use in patients with metastatic RET fusion-positive non-small cell lung cancer, in adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer, and in adult and pediatric patients 12 years of age and older with RET fusion-positive thyroid cancer who are radioactive iodine-refractory (FDA.gov).

DrugClasses RET Inhibitor 52
CAS Registry Number 2097132-94-8
NCIT ID C132295

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Afatinib + Pralsetinib Afatinib Pralsetinib 0 0
Crizotinib + Pralsetinib Crizotinib Pralsetinib 0 0
Ensartinib + Pralsetinib Ensartinib Pralsetinib 0 0
JC-010a + Pralsetinib JC-010a Pralsetinib 0 0
Osimertinib + Pralsetinib Osimertinib Pralsetinib 0 0
Palbociclib + Pralsetinib Palbociclib Pralsetinib 0 0
Pralsetinib Pralsetinib 52 5


Additional content available in CKB BOOST